date,title,source
Nov-08-18,Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors,PR Newswire
Nov-13-18,"Sutro Announces IND Submission and Conclusion of 30-Day Review Period for STRO-002, an Antibody-Drug Conjugate (ADC) Targeting Anti-Folate Receptor- for Treatment of Ovarian and Endometrial Cancer",PR Newswire
